Raymond James Financial Services Advisors’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-84,605
| Closed | -$347K | – | 3381 |
|
|
2022
Q1 | $347K | Sell |
84,605
-9,843
| -10% | -$40.4K | ﹤0.01% | 2608 |
|
|
2021
Q4 | $337K | Sell |
94,448
-1,255
| -1% | -$4.48K | ﹤0.01% | 2628 |
|
|
2021
Q3 | $348K | Buy |
95,703
+4,561
| +5% | +$16.6K | ﹤0.01% | 2587 |
|
|
2021
Q2 | $397K | Buy |
91,142
+2,004
| +2% | +$8.73K | ﹤0.01% | 2530 |
|
|
2021
Q1 | $366K | Sell |
89,138
-5,961
| -6% | -$24.5K | ﹤0.01% | 2498 |
|
|
2020
Q4 | $379K | Sell |
95,099
-113,251
| -54% | -$451K | ﹤0.01% | 2312 |
|
|
2020
Q3 | $563K | Sell |
208,350
-16,122
| -7% | -$43.6K | ﹤0.01% | 1888 |
|
|
2020
Q2 | $617K | Buy |
224,472
+9,895
| +5% | +$27.2K | ﹤0.01% | 1772 |
|
|
2020
Q1 | $506K | Buy |
214,577
+113,836
| +113% | +$268K | ﹤0.01% | 1542 |
|
|
2019
Q4 | $473K | Sell |
100,741
-18,499
| -16% | -$86.9K | ﹤0.01% | 2019 |
|
|
2019
Q3 | $399K | Buy |
119,240
+4,224
| +4% | +$14.1K | ﹤0.01% | 2046 |
|
|
2019
Q2 | $378K | Buy |
115,016
+11,880
| +12% | +$39K | ﹤0.01% | 2106 |
|
|
2019
Q1 | $313K | Sell |
103,136
-70,843
| -41% | -$215K | ﹤0.01% | 2214 |
|
|
2018
Q4 | $473K | Buy |
173,979
+40,365
| +30% | +$110K | ﹤0.01% | 1709 |
|
|
2018
Q3 | $449K | Sell |
133,614
-12,420
| -9% | -$41.7K | ﹤0.01% | 2001 |
|
|
2018
Q2 | $377K | Sell |
146,034
-2,012
| -1% | -$5.19K | ﹤0.01% | 2072 |
|
|
2018
Q1 | $326K | Sell |
148,046
-32,620
| -18% | -$71.8K | ﹤0.01% | 1983 |
|
|
2017
Q4 | $360K | Buy |
180,666
+46,766
| +35% | +$93.2K | ﹤0.01% | 1912 |
|
|
2017
Q3 | $434K | Buy |
133,900
+38,475
| +40% | +$125K | ﹤0.01% | 1800 |
|
|
2017
Q2 | $307K | Buy |
+95,425
| New | +$307K | ﹤0.01% | 1972 |
|